Abstract:BACKGROUND:Distinguishing between multiple primary lung cancers and metastatic tumors is often difficult when the tumor histology is same. Since genomic instability is a common feature of cancer, we hypothesized that independently arising neoplasms in an individual patient would exhibit measurable genomic variation, enabling discrimination of tumor lineage and relatedness. The feasibility of analyzing genomic instability expression profiles to distinguish multiple primary lung cancers from metastatic tumors was evaluated.METHODS:This study enrolled 13 patients, with multiple primary lung cancers demonstrating with the histology, who underwent surgery between April 2003 and December 2012 at the Department of the Thoracic Surgery at West China Hospital in Sichuan province of China and 10 patients who were diagnosed as metastasis disease during the same period for comparison purposes. Genomic DNA from lung cancers from individual patients was analyzed by six microsatellites (D2S1363, D6S1056, D7S1824, D10S1239, D15S822, and D22S689) with PCR to identify discordant allelic variation. The experiments were approved by the West China Hospital Ethics committee (No.2013 (33)) and all patients agreed to participate in the study and signed an informed consent form.RESULTS:All of the 10 patients with distant metastasis showed a consistent consequence that we called "unique trend" between primary tumor and distant metastasis. The "trend" is representive in this study, which means that all alleles corresponding to six microsatellite markers were detected in DNA from primary tumors but were reduced or not observed in DNA from metastatic tumors. In the group of synchronous lung tumor with different histological types, the result showed a "contradictory trend". Some alleles were detected in DNA from primary tumors but were reduced or not observed in DNA from metastatic tumors and other alleles corresponding to six microsatellite markers were detected in DNA from metastatic tumors but were reduced or not observed in DNA from primary tumors. In the third group (synchronous lung tumor with same histological types), 2 of 8 patients showed "unique trend" and the others showed "contradictory trend".CONCLUSIONS:With polymorphic microsatellite markers, the "unique trend" that represents metastasis cancers and the "contradictory trend" that represents primary multiple tumors are useful in the diagnosis between tumors found at the same time in the pulmonary even diagnosed with the histopathological evaluation from a single patient.

Method for Discriminating Synchronous Multiple Lung Cancers of the Same Histological Type: Mirna Expression Analysis.

[Synchronous Multiple Primary Lung Cancer Dignosed by Different Phenotype-genotype: A Case Report and Literature Review].

Two Plasma Microrna Panels for Diagnosis and Subtype Discrimination of Lung Cancer

Genetic, DNA Methylation, and Immune Profile Discrepancies Between Early-Stage Single Primary Lung Cancer and Synchronous Multiple Primary Lung Cancer

Genetic and Immune Profile Discrepancies between Early-Stage Single Primary Lung Cancer and Synchronous Multiple Primary Lung Cancer

Identification of miRNA Biomarkers for Non-small Cell Lung Cancer using Microarray Datasets and Bioinformatics Analysis

Genomic Heterogeneity of Multiple Synchronous Lung Cancer

Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases

Bioinformatics Analysis Of Differentially Expressed Mirnas In Non-Small Cell Lung Cancer

Microsatellite Alteration in Plasma DNA Discriminates Multiple Primary Lung Cancer from Metastatic Lung Cancer

MicroRNA‐based Biomarkers for Diagnosis of Non‐small Cell Lung Cancer (NSCLC)

Two Microrna Panels to Discriminate Three Subtypes of Lung Carcinoma in Bronchial Brushing Specimens

A Comprehensive Algorithm to Distinguish Between MPLC and IPM in Multiple Lung Tumors Patients.

High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer

Classification of multiple primary lung cancer in patients with multifocal lung cancer: assessment of a machine learning approach using multidimensional genomic data

Molecular Characterization of Lung Cancer: A Two-Mirna Prognostic Signature Based on Cancer Stem-Like Cells Related Genes.

A comprehensive in silico analysis and experimental validation of miRNAs capable of discriminating between lung adenocarcinoma and squamous cell carcinoma

OP0016 Development of a panel of five miRNAs as a diagnostic tool for non-small-cell lung cancer

A Novel Differential Diagnostic Model for Multiple Primary Lung Cancer: Differentially-expressed Gene Analysis of Multiple Primary Lung Cancer and Intrapulmonary Metastasis.

Differential Expression Profiles of Micrornas As Potential Biomarkers for the Early Diagnosis of Lung Cancer.

“Unique Trend” and “contradictory Trend” in Discrimination of Primary Synchronous Lung Cancer and Metastatic Lung Cancer